The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas (original) (raw)

Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus

macro mark

BMC Genomics, 2007

View PDFchevron_right

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Andreas Unterberg

The Lancet. Oncology, 2017

View PDFchevron_right

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

David Raleigh

Nature Genetics

View PDFchevron_right

DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade

Anna-Maria Barciszewska

Journal of Cancer Research and Clinical Oncology, 2015

View PDFchevron_right

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets

Stefania Bartolini

Diagnostics, 2021

View PDFchevron_right

Genetic and epigenetic alterations in meningiomas

Evangeli Lampri

Clinical Neurology and Neurosurgery, 2017

View PDFchevron_right

Meningioma epigenetic grouping reveals biologic drivers and therapeutic vulnerabilities

David Raleigh

2020

View PDFchevron_right

Epigenetics of Meningiomas

László Bognár

BioMed Research International, 2015

View PDFchevron_right

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma

Annika Wefers

Acta Neuropathologica, 2019

View PDFchevron_right

Meningioma: A Pathology Perspective

Kristin Huntoon

Neurosurgery, 2021

View PDFchevron_right

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

Leah Katz

Acta neuropathologica

View PDFchevron_right

Pathodiagnostic parameters and evaluation of O6– methyl guanine methyl transferase gene promoter methylation in meningiomas

sima afsharnezhad

Gene, 2014

View PDFchevron_right

The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications

Sagar Vasandani

Journal of Neuro-oncology, 2021

View PDFchevron_right

Genetic/molecular alterations of meningiomas and the signaling pathways targeted

Alberto Orfao

Oncotarget, 2015

View PDFchevron_right

Molecular Biological Determinations of Meningioma Progression and Recurrence

Stefan Linsler

PLoS ONE, 2014

View PDFchevron_right

Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMO

Yasar Bayri

Science, 2013

View PDFchevron_right

Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms

Steven Giannotta

Neurosurgical focus, 2011

View PDFchevron_right

Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

C. Herold-mende

Acta Neuropathologica, 2020

View PDFchevron_right

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

Annika Wefers

Journal of Clinical Oncology, 2021

View PDFchevron_right

MOLECULAR GENETICS OF MENINGIOMAS: FROM BASIC RESEARCH TO POTENTIAL CLINICAL APPLICATIONS TOPIC REVIEW

Kevin Gunawan

View PDFchevron_right

EPCO-40. Infratentorial NF2 Mutant Sporadic Meningiomas Differ from Those in Supratentorial Locations and Are More Benign

Sagar Vasandani

Neuro-Oncology

View PDFchevron_right

NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas

Juan Carlos Rey, Ph.D.

Oncogene, 1999

View PDFchevron_right

Aggressive Phenotypic and Genotypic Features in Pediatric and NF2-Associated Meningiomas: A Clinicopathologic Study of 53 Cases

David Gutmann

Journal of Neuropathology & Experimental Neurology, 2001

View PDFchevron_right

DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q

Manuel Gutierrez

Acta Neuropathologica, 2004

View PDFchevron_right

Integrated genomic analyses of de novo pathways underlying atypical meningiomas

Burçin Baran

Nature communications, 2017

View PDFchevron_right

The Loss of 1p as a Reliable Marker of Progression in a Child with Aggressive Meningioma: A 16-Year Follow-Up Case Report

Joachim Oertel

Pediatric Neurosurgery, 2020

View PDFchevron_right

NF2 gene expression in sporadic meningiomas: Relation to grades or histotypes real time-PCR study

Gian Luigi Taddei

Neuropathology, 2007

View PDFchevron_right